BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37698017)

  • 1. Altered Smooth Muscle Cell Histone Acetylome by the SPHK2/S1P Axis Promotes Pulmonary Hypertension.
    Ranasinghe ADCU; Holohan M; Borger KM; Donahue DL; Kuc RD; Gerig M; Kim A; Ploplis VA; Castellino FJ; Schwarz MA
    Circ Res; 2023 Sep; 133(8):704-719. PubMed ID: 37698017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smooth muscle cell-specific FoxM1 controls hypoxia-induced pulmonary hypertension.
    Dai J; Zhou Q; Tang H; Chen T; Li J; Raychaudhuri P; Yuan JX; Zhou G
    Cell Signal; 2018 Nov; 51():119-129. PubMed ID: 30092353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical role of VGLL4 in the regulation of chronic normobaric hypoxia-induced pulmonary hypertension in mice.
    Tian Q; Fan X; Ma J; Li D; Han Y; Yin X; Wang H; Huang T; Wang Z; Shentu Y; Xue F; Du C; Wang Y; Mao S; Fan J; Gong Y
    FASEB J; 2021 Aug; 35(8):e21822. PubMed ID: 34314061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPARC, a Novel Regulator of Vascular Cell Function in Pulmonary Hypertension.
    Veith C; Vartürk-Özcan I; Wujak M; Hadzic S; Wu CY; Knoepp F; Kraut S; Petrovic A; Gredic M; Pak O; Brosien M; Heimbrodt M; Wilhelm J; Weisel FC; Malkmus K; Schäfer K; Gall H; Tello K; Kosanovic D; Sydykov A; Sarybaev A; Günther A; Brandes RP; Seeger W; Grimminger F; Ghofrani HA; Schermuly RT; Kwapiszewska G; Sommer N; Weissmann N
    Circulation; 2022 Mar; 145(12):916-933. PubMed ID: 35175782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylation contributes to low extracellular superoxide dismutase expression in human idiopathic pulmonary arterial hypertension.
    Nozik-Grayck E; Woods C; Stearman RS; Venkataraman S; Ferguson BS; Swain K; Bowler RP; Geraci MW; Ihida-Stansbury K; Stenmark KR; McKinsey TA; Domann FE
    Am J Physiol Lung Cell Mol Physiol; 2016 Jul; 311(1):L124-34. PubMed ID: 27233998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary artery smooth muscle cell proliferation and migration in fetal lambs acclimatized to high-altitude long-term hypoxia: role of histone acetylation.
    Yang Q; Lu Z; Ramchandran R; Longo LD; Raj JU
    Am J Physiol Lung Cell Mol Physiol; 2012 Dec; 303(11):L1001-10. PubMed ID: 23043075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial HIF-2α contributes to severe pulmonary hypertension due to endothelial-to-mesenchymal transition.
    Tang H; Babicheva A; McDermott KM; Gu Y; Ayon RJ; Song S; Wang Z; Gupta A; Zhou T; Sun X; Dash S; Wang Z; Balistrieri A; Zheng Q; Cordery AG; Desai AA; Rischard F; Khalpey Z; Wang J; Black SM; Garcia JGN; Makino A; Yuan JX
    Am J Physiol Lung Cell Mol Physiol; 2018 Feb; 314(2):L256-L275. PubMed ID: 29074488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic regulation of SPHK1 expression and translocation by EMAP II in pulmonary smooth muscle cells.
    Ranasinghe ADCU; Lee DD; Schwarz MA
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Dec; 1865(12):158789. PubMed ID: 32771459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingosine Kinase 1 Deficiency in Smooth Muscle Cells Protects against Hypoxia-Mediated Pulmonary Hypertension via YAP1 Signaling.
    Chen J; Lockett A; Zhao S; Huang LS; Wang Y; Wu W; Tang M; Haider S; Velez Rendon D; Khan R; Liu B; Felesena N; Sysol JR; Valdez-Jasso D; Tang H; Bai Y; Natarajan V; Machado RF
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Ca(2+)-sensing receptor function in idiopathic pulmonary arterial hypertension.
    Yamamura A; Guo Q; Yamamura H; Zimnicka AM; Pohl NM; Smith KA; Fernandez RA; Zeifman A; Makino A; Dong H; Yuan JX
    Circ Res; 2012 Aug; 111(4):469-81. PubMed ID: 22730443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
    Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
    Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAR-2 inhibition reverses experimental pulmonary hypertension.
    Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
    Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic role of calcium-sensing receptors in the development and progression of pulmonary hypertension.
    Tang H; Yamamura A; Yamamura H; Song S; Fraidenburg DR; Chen J; Gu Y; Pohl NM; Zhou T; Jiménez-Pérez L; Ayon RJ; Desai AA; Goltzman D; Rischard F; Khalpey Z; Black SM; Garcia JG; Makino A; Yuan JX
    Am J Physiol Lung Cell Mol Physiol; 2016 May; 310(9):L846-59. PubMed ID: 26968768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulated Smooth Muscle Cell BMPR2-ARRB2 Axis Causes Pulmonary Hypertension.
    Wang L; Moonen JR; Cao A; Isobe S; Li CG; Tojais NF; Taylor S; Marciano DP; Chen PI; Gu M; Li D; Harper RL; El-Bizri N; Kim YM; Stankunas K; Rabinovitch M
    Circ Res; 2023 Mar; 132(5):545-564. PubMed ID: 36744494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow shear stress enhances intracellular Ca2+ signaling in pulmonary artery smooth muscle cells from patients with pulmonary arterial hypertension.
    Song S; Yamamura A; Yamamura H; Ayon RJ; Smith KA; Tang H; Makino A; Yuan JX
    Am J Physiol Cell Physiol; 2014 Aug; 307(4):C373-83. PubMed ID: 24920677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sphingosine kinase 1/sphingosine-1-phosphate pathway in pulmonary arterial hypertension.
    Chen J; Tang H; Sysol JR; Moreno-Vinasco L; Shioura KM; Chen T; Gorshkova I; Wang L; Huang LS; Usatyuk PV; Sammani S; Zhou G; Raj JU; Garcia JG; Berdyshev E; Yuan JX; Natarajan V; Machado RF
    Am J Respir Crit Care Med; 2014 Nov; 190(9):1032-43. PubMed ID: 25180446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulation of the IL-13 receptor system: a novel pathomechanism in pulmonary arterial hypertension.
    Hecker M; Zaslona Z; Kwapiszewska G; Niess G; Zakrzewicz A; Hergenreider E; Wilhelm J; Marsh LM; Sedding D; Klepetko W; Lohmeyer J; Dimmeler S; Seeger W; Weissmann N; Schermuly RT; Kneidinger N; Eickelberg O; Morty RE
    Am J Respir Crit Care Med; 2010 Sep; 182(6):805-18. PubMed ID: 20522789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA Hoxaas3 contributes to hypoxia-induced pulmonary artery smooth muscle cell proliferation.
    Zhang H; Liu Y; Yan L; Wang S; Zhang M; Ma C; Zheng X; Chen H; Zhu D
    Cardiovasc Res; 2019 Mar; 115(3):647-657. PubMed ID: 30304383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergent changes of p53 in pulmonary arterial endothelial and smooth muscle cells involved in the development of pulmonary hypertension.
    Wang Z; Yang K; Zheng Q; Zhang C; Tang H; Babicheva A; Jiang Q; Li M; Chen Y; Carr SG; Wu K; Zhang Q; Balistrieri A; Wang C; Song S; Ayon RJ; Desai AA; Black SM; Garcia JGN; Makino A; Yuan JX; Lu W; Wang J
    Am J Physiol Lung Cell Mol Physiol; 2019 Jan; 316(1):L216-L228. PubMed ID: 30358436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of hypoxia-inducible factor functions in the nucleus by sphingosine-1-phosphate.
    Hait NC; Maiti A; Xu P; Qi Q; Kawaguchi T; Okano M; Takabe K; Yan L; Luo C
    FASEB J; 2020 Mar; 34(3):4293-4310. PubMed ID: 32017264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.